paclitaxel has been researched along with Complex and Mixed Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glass, LF; Jukic, DM; McNab, PM; Quigley, BC | 1 |
Chen, W; He, Y; Peng, J; Song, W; Zhang, S | 1 |
1 review(s) available for paclitaxel and Complex and Mixed Neoplasms
Article | Year |
---|---|
Composite hemangioendothelioma and its classification as a low-grade malignancy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Biopsy; Child; Drug Administration Schedule; Female; Hemangioendothelioma; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Grading; Neoplasms, Complex and Mixed; Paclitaxel; Predictive Value of Tests; Skin Neoplasms; Terminology as Topic; Treatment Outcome; Young Adult | 2013 |
1 other study(ies) available for paclitaxel and Complex and Mixed Neoplasms
Article | Year |
---|---|
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carboplatin; Carcinoma, Neuroendocrine; Cystectomy; Etoposide; Female; Gallbladder Neoplasms; Hepatectomy; Humans; Immunohistochemistry; Liver Neoplasms; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasms, Complex and Mixed; Octreotide; Paclitaxel; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |